Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Alkermes plc's (NASDAQ:ALKS) Q4 sales increased 16% Y/Y to $324.5 million, beating the consensus of $308.69 million.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Net sales of proprietary products were $178.9 million, compared to $148.96 million in the prior year.
- Net sales of Vivitrol were $92.04 million, compared to $80.05 million in the prior year. Net sales of Aristada were $78.67 million, compared to $68.91 million.
- Manufacturing and royalty revenues were $143.37 million, compared to $130.89 million in the prior year.
- Royalty revenues from the long-acting INVEGA products were $81.14 million, compared to $76.52 million in the prior year.
- The Company reported an adjusted EPS of $0.23, compared to $0.10, beating the consensus of $0.11.
- Related: Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia.
- Guidance: Alkermes expects FY22 sales of $1 billion - $1.09 billion, below the consensus of $1.15 billion.
- The outlook expects Vivitrol sales of $355 million – $385 million, Aristada revenues of $290 million – $320 million, and Lybalvi sales of $55 million – $75 million.
- For FY22, the Company expects adjusted EPS of ($0.18) – $0.00, compared to the Wall Street estimate of $0.35.
- Price Action: ALKS shares are trading 13.30% higher at $26.40 on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.